Thu, 17 August 2017
A solar eclipse occurs Monday -- what that means for solar producers may surprise you. |
Wed, 16 August 2017
With a slate of promising drugs hitting the market and in its development pipeline, Regeneron Pharmaceuticals is becoming one of biotechs most important players. |
Tue, 15 August 2017
For several years, Procter & Gamble has been spinning off low-priority brands and cutting costs to streamline its business. But with little to show for those efforts, billionaire Nelson Peltz wants a seat at the table. Meanwhile, a slow summer blockbuster season is taking a major toll on theater operators. |
Mon, 14 August 2017
Business development companies are undergoing a sea change as the asset class becomes more institutionalized. |
Fri, 11 August 2017
Snap's quarterly update was... uninspiring. On this show, we talk about the updated user counts, ask some questions on engagement metrics, and run through the new financials. |
Thu, 10 August 2017
Fracking has been the oil industry buzzword for years, here’s what the process actually means. |
Wed, 9 August 2017
Scotts Miracle Gro could be the best marijuana stock to buy, while Illumina could be the best bet to capitalize on DNA-based medicine. |
Tue, 8 August 2017
You might not be able to fire the coach or have a say in drafting new players, but there are ways to invest in professional sports. |
Mon, 7 August 2017
Here's the differences between the major credit card processors, and how to evaluate them as investments. |
Fri, 4 August 2017
We try and decode what's going on with Twitter's DAU/MAU numbers, and run through the figures on another banner quarter for the world's largest company. |